Skip to main content

Mometasone / olopatadine nasal Side Effects

Medically reviewed by Drugs.com. Last updated on Sep 10, 2023.

Applies to mometasone/olopatadine nasal: nasal spray.

Serious side effects

Along with its needed effects, mometasone/olopatadine nasal may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking mometasone / olopatadine nasal:

Less common

Rare

Incidence not known

Other side effects

Some side effects of mometasone / olopatadine nasal may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

For Healthcare Professionals

Applies to mometasone / olopatadine nasal: nasal spray.

General

The most common adverse reactions were dysgeusia (substance-specific unpleasant taste), epistaxis, and nasal discomfort.[Ref]

Dermatologic

Rare (0.01% to 0.1%): Laceration[Ref]

Gastrointestinal

Common (1% to 10%): Nausea

Uncommon (0.1% to 1%): Dry mouth, abdominal pain, nausea

Rare (0.01% to 0.1%): Constipation, sore tongue[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection

Rare (0.01% to 0.1%): Bacterial vaginosis[Ref]

Hypersensitivity

Corticosteroids:

-Frequency not reported: Hypersensitivity (including anaphylactic reactions, angioedema, bronchospasm, dyspnea)

Mometasone nasal:

-Frequency not reported: Hypersensitivity reactions (including wheezing)[Ref]

Musculoskeletal

Common (1% to 10%): Back pain

Nasal corticosteroids:

-Frequency not reported: Growth retardation in children/reduction in growth velocity in pediatric patients[Ref]

Nervous system

Common (1% to 10%): Dysgeusia (unpleasant taste), headache

Uncommon (0.1% to 1%): Dizziness, somnolence, lethargy

Rare (0.01% to 0.1%): Migraine[Ref]

Ocular

Rare (0.01% to 0.1%): Blurred vision, dry eye, eye discomfort

Corticosteroids:

-Frequency not reported: Cataracts, glaucoma, increased intraocular pressure[Ref]

Other

Common (1% to 10%): Procedural pain

Uncommon (0.1% to 1%): Fatigue

Rare (0.01% to 0.1%): Ear pain[Ref]

Psychiatric

Uncommon (0.1% to 1%): Insomnia

Rare (0.01% to 0.1%): Anxiety, depression[Ref]

Respiratory

Common (1% to 10%): Epistaxis, nasal discomfort, upper respiratory infection, viral upper respiratory tract infection, cough, bronchitis, streptococcal pharyngitis

Uncommon (0.1% to 1%): Nasal dryness, nasal inflammation, oropharyngeal pain, throat irritation, sneezing

Rare (0.01% to 0.1%): Nasal mucosal disorder

Corticosteroids:

-Frequency not reported: Pharyngitis, upper respiratory tract infection, nasal septum perforation

Mometasone nasal:

-Frequency not reported: Localized Candida albicans infections of the nose and pharynx

Nasal antihistamines:

-Frequency not reported: Nasal ulceration, nasal septal perforation[Ref]

References

1. Product Information. Ryaltris (mometasone-olopatadine nasal). Hikma Americas, Inc. 2022;ORIG-1.

2. Product Information. Ryaltris (mometasone-olopatadine nasal). Seqirus Pty Ltd. 2022.

3. Product Information. Ryaltris (mometasone-olopatadine nasal). Glenmark Pharmaceuticals Europe Ltd. 2021.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.